PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in the majority of genes known to be associated with cardiomyopathies, a collection of cardiac diseases characterized by defects in myocardia (i.e., cardiac muscle). Genetic variants at multiple loci have been associated with various forms of cardiomyopathy (e.g., dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy). These reagents are intended to detect mutations in the majority of cardiomyopathy-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286622_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286622_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all